与单克隆抗体结合的人工跨膜基蛋白干扰 mRNA 提高癌症免疫疗法的特异性和有效性
Yinyu Yan1, Zijiang Luo1, Xinyuan Hu1
1Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, China.
Advanced materials (Deerfield Beach, Fla.)
|September 2, 2025
概括
一种新的纳米粒子系统结合了mRNA和抗体来增强癌症免疫治疗. 这种方法改善了瘤抑制,并通过直接向细胞输送治疗有效载荷来降低毒性.
科学领域:
- 生物技术
- 免疫学
- 纳米医学
背景情况:
- 提高癌症免疫治疗反应率,同时降低毒性是一个关键的挑战.
- 组合疗法经常面临有效载荷传递和副作用的问题.
研究的目的:
- 开发一种用于增强癌症免疫治疗的新型纳米粒子系统.
- 结合编码干扰素β (IFNβ) 和抗PD- L1单克隆抗体 (aPD- L1) 的mRNA.
- 提高治疗效果并降低全身毒性.
主要方法:
- 用于mRNA和抗体复合的胆固醇移植多素 (CPL) 的合成.
- 形成CmRi纳米颗粒 (CPL与IFNβmRNA复合) 和aCmRi纳米颗粒 (表面修饰与aPD-L1).
- 在体外RNA测序和体内B16- F10黑色素瘤小鼠模型研究.
主要成果:
- 通过CPL促进了mRNA的细胞分泌,绕过了 lysosomal 降解.
- aCmRi纳米颗粒促进了瘤细胞的亡,并提高了MHC I的表达.
- aCmRi配方实现了89. 9%的瘤抑制率,mRNA转染率高 (26. 1%),没有显著的毒性.
结论:
- 开发的aCmRi纳米粒子系统有效增强瘤免疫疗法.
- 这种策略结合了向性治疗,免疫激活和减少副作用.
- 它提供了一种提高癌症免疫疗法的有效性,选择性和安全性的多功能平台.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


